{"name":"Braeburn Pharmaceuticals","slug":"braeburn-pharmaceuticals","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxOdU5HQjJTbTZIMUtta29jWXRGSURCMFQwV1p6dU9sWXNhYXM0eVVRQVUtc0NUdVhtWFJsN3pCRzhFcXdnMGFOV1dkM2VCOXVCWWxqdnBmOGhTdS1fR09SU3hqXzRmMElOUlRjNXhidkZ6UlBZcHBSWjh4VWxRY1JmVHEtRQ?oc=5","date":"2025-09-15","type":"deal","source":"pharmaphorum","summary":"Rumour mill has Camurus buying partner Braeburn - pharmaphorum","headline":"Rumour mill has Camurus buying partner Braeburn","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxOUWlXamNoYnBqNjV2YUtONjg4Z2hCa25YRGtTQy0zb1pha05BQUZsaVlua0VsaGVYVS1laEY5N0g2NGgxenJjOV84ZlY1QjBmWlRwbDdXVGhmQ3MzRlliRVVKTS1JMjJfVE1BUnBQV2xNR2p2U3V4M2N3VU5UUy1fdmZNN2VoNWdUNVF3MlRqNF9wOUVfWXBPVTRBX1h3N0lMM3RWWkxOMC1iUQ?oc=5","date":"2025-09-15","type":"regulatory","source":"statnews.com","summary":"Pharmalittle: We're reading about FDA targeting Hims & Hers, AstraZeneca halting U.K. investment, and more - statnews.com","headline":"Pharmalittle: We're reading about FDA targeting Hims & Hers, AstraZeneca halting U.K. investment, and more","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxPSlRrZUk3MHdNV3FsWnFTN3NvaG9hcmFEQWlHeGNkZnJqWkxxZk9GODFuQWhxU2lyVzlLTFhNSVJWS1NzYzkzMHdLcWttMVEyYmRKXzRuSFJTSjNRMUJONmZvekQ4T3RKZlBaV2I0TWNkZk5EY1FqYXN2My1sTEJVYzRkdUhPMUpTZEhPREN0MElnREk1WFU5RQ?oc=5","date":"2025-09-12","type":"deal","source":"Modern Diplomacy","summary":"Big Pharma Deal: Swedish Camurus to Acquire US Braeburn? - Modern Diplomacy","headline":"Big Pharma Deal: Swedish Camurus to Acquire US Braeburn?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0AFBVV95cUxPSHVCdEd0U2NnUzBCeVV5czFYa0RHQ09uMUtoaElfQ0NXaHdPckZZUzF4akZweUFKc2QxM2Jlam9RR0RZWUtqb2dsVGFacU9XZDM5QjNQWG5ScGtCMFA4QlhEUDNSeUdHdjViWnNvN1FHYkItUHFJYklPbUczd2FndHlYN1Z5dU9SRE82LXk3NERzYVB2cGtkeVhTQWk4YkVURDFNdHZZT0NrbUk5S1RBeUNrRDdSNE90LUQwcndDaUk2cTlKNjlQa3VpSUdDdXFK?oc=5","date":"2025-09-12","type":"deal","source":"EU Reporter","summary":"Swedish Biotech Camurus in Talks to Buy US-Based Braeburn in $1 Billion Opioid Market Bet - EU Reporter","headline":"Swedish Biotech Camurus in Talks to Buy US-Based Braeburn in $1 Billion Opioid Market Bet","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMidkFVX3lxTE1HcWtyLXktdkVmdnp6c0xiMk9lc3FMRVBWWnhuYk1kVk16N0JGN2NzYXM5bFpzcXlMaC1GWnF1bVVDWUQ4anpzWUJfNi0tajJLTi1BXzJCZ2tVUUZxOG1vQ0d3c1M4VG9KR3VGaUlEZVM4TFlHdHc?oc=5","date":"2024-07-22","type":"pipeline","source":"Pharmaceutical Executive","summary":"Braeburn on BRIXADI® Research and Addressing Fentanyl's Impact on OUD - Pharmaceutical Executive","headline":"Braeburn on BRIXADI® Research and Addressing Fentanyl's Impact on OUD","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxPbnNFTU50LUJUSGxwUTV0LXBzVXFoQ1o4V0dXQmpLZ1RSVTB4bjZwZExIdk1DTlo2VVl1bllUY09OemNpcUE3TnlJTVk3eWRFVnhmb01tMlVFZ2dqQ3VhNktROGc4QllMODlyVVdtSUYyUlhldGZVektPbTlwTFdqMzl4dGkxdHdudjhvYmJ5MWhFdllOTUdzZ0w1RDJ1YkZa?oc=5","date":"2023-05-24","type":"regulatory","source":"Fierce Pharma","summary":"FDA clears Braeburn's long-acting Brixadi to treat opioid use disorder - Fierce Pharma","headline":"FDA clears Braeburn's long-acting Brixadi to treat opioid use disorder","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxOcC1mNS1RTDhWMjlIbzlnUGdaVktuS2xmNWg2TXh3NWJzZEtnNmw1OUMzVGJUUFFBQ21OVEl6b2pOTlhtajFhdTFlSlRaX0FYLTNjYW1JWktqN3haU0FqYmh4bG5oZnpDRF9RTVY2b3NDcERpd3lXVm1rZHhJdUJSSEY3ckhlVlhKTHhaeWZmVFFpZGwxZlZwZG9SSUZvdTZQeTA5WFdwZGN0WHNFWWc?oc=5","date":"2023-05-23","type":"regulatory","source":"The Business Journals","summary":"Braeburn gets FDA approval for opioid use disorder drug after more than 4-year battle - The Business Journals","headline":"Braeburn gets FDA approval for opioid use disorder drug after more than 4-year battle","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxPZ01xRFlJZW5rZ1NudlRqYlhhaDQ3TXVZSVBjaEp2RmwtWkhrWXV1aUR3b0N4YzBPUjBvcDI5WE4zSVA0ZHp0RE5kNWZ5dHQzbHR5NmEzakM5aklhZU4wTGViN2JrYzhVM0hxLVlubVdRazdIMFdqVDhRbDZRa1loemJIZXVLLUtxS21RYTVSdzdmUjRtUGNNTw?oc=5","date":"2018-01-22","type":"pipeline","source":"BioPharma Dive","summary":"Braeburn hits setback with CRL for opioid disorder - BioPharma Dive","headline":"Braeburn hits setback with CRL for opioid disorder","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAJBVV95cUxPR1lydHFvdHlpLS1odnhxQ1VCbXBTZ0p1Wkhhb01CY3htb2Y2V1ZTaGRvMVdwTV9handlWVgyeVVnbEJZWnBPYVg3YVU5bVhUelJWVnkzN0hrTllLZ2VFd3N0LWxSQS1zV1g5NENhZ2JQU0E3Mmw0bHpKUEZfLTJ3bmtMWjcwbGpsUUdycHlqZ3F2WmY3WjIyYk9IVUZheW1rSG9DaTBxMVg3LXZvZVdWSGpTOW03TFh6VTlqOVNEQlhxWUZNYkk4OWh2RFE0YXdKT3dpX3lhZk1FcmowYjFUWHBGRXJJcVVCSi1WYjlmYW41ZUh2OEh3RnR5aFUwaXVndkQ0ZzEzZmhSdlk3ZVBzM2x1NmRYZ1EyOHlqWGptLXJ0YWdNUlNrbQ?oc=5","date":"2017-04-26","type":"trial","source":"prnewswire.com","summary":"Braeburn Pharmaceuticals Achieves Primary Endpoint in Pivotal Phase 2/3 Study of BB0817, Risperidone 6-month Implant for Treatment of Schizophrenia - prnewswire.com","headline":"Braeburn Pharmaceuticals Achieves Primary Endpoint in Pivotal Phase 2/3 Study of BB0817, Risperidone 6-month Implant for","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxQNjJCYzNyc3dUNEZqbVBXQW9pWjlPQUFpVEJRTU9BXzA5NE4tVGd3LXBzcFphb2tRWWpWMzVNZXF4N2RVYnlTV0Y1S3NXcWFxb293U3U4cjFTVk5ISXM1em9JN1B4S2dPTzQ3RE5MMHVoOG9JUWJmOGgtZVl3MXFYSkJUUjBTNFEtM21vQUhxVGxRZC12WVE?oc=5","date":"2017-02-03","type":"pipeline","source":"drugdeliverybusiness.com","summary":"Braeburn pulls the plug on $150m IPO, citing market conditions - drugdeliverybusiness.com","headline":"Braeburn pulls the plug on $150m IPO, citing market conditions","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxOc0VxdHhCdkZkbVBuOE9zMmZmcTRabUVwWUFsSUxaVm1FRW02MHpSMUp2cjExZ1pEXzdHWU9felNGZ21DYS1zTjdpVFdFMU51WVJNRlNiSG1kSmlqb1NMUEEwVmF5WVlKT25WMTBFX2pDYUZCQ29tY1pMM1QweFUzMGJ5S0tJbzY2QnFUWkRsb3pvemdyRGc?oc=5","date":"2016-05-17","type":"pipeline","source":"CNBC","summary":"Braeburn Pharma pushes forward with NC facility - CNBC","headline":"Braeburn Pharma pushes forward with NC facility","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgJBVV95cUxNQ2lVR2xGZjhmaVRmRlRSbWlGVm9PRUV1MmFNTHczZjNOQkFjT2ZpcTVWNEFDcDNMZHh4SkhuMDFxSEp4NXNxRnRJN2NHRGF0ZUNob3p5M0dkbHNGV09RajBnVzM4VXlJNDlBYi1naldrbUtrbUpKRVBySHNvTW5fRTlOVmVhT1ZBZmhaaXpjWHNLZjIzekFJZlNmeFBDbWJuZDFmZ1B2SEpJTC1vSTBFcjFEWWlTN2hTS05tQjN5cmxfVTBKcVVUdnVfZlhHc2V2SEJhc0hTQzFueDBZNjlWNVZXSlo1ZHBlTlIyMzBqNmtrU2tKRE5fN2RnaDRqdE9Kb3FVdFlKa0ExRW82b3dIMUQ1MVVnajI0V1NTSllxUzVacHZrdElSb0dVSURlZw?oc=5","date":"2014-11-20","type":"deal","source":"prnewswire.com","summary":"Camurus and Braeburn Pharmaceuticals sign exclusive license for long-acting buprenorphine injectables for the treatment of opioid dependence and pain - prnewswire.com","headline":"Camurus and Braeburn Pharmaceuticals sign exclusive license for long-acting buprenorphine injectables for the treatment ","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}